[Editor's Note: A version of this article originally appeared in Scrip. For more insight on the the B+L spin-off from the perspective of the over-the-counter industry, see Informa's HBW Insight. For a thorough overview of the $9.1bn global ophthalmic surgery device industry, read Informa Meddevicetracker's latest report on this market.]
Bausch Hopes B+L Spin-Out Will 'Unlock' The Value Of Eye-Care Business
Bausch Health is paying down its debt with a $630m IPO for its Bausch + Lomb eyecare product business.
